Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001055157 | SCV001219529 | pathogenic | Hereditary hemochromatosis | 2023-06-20 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Pro388Leufs*12) in the TFR2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TFR2 are known to be pathogenic (PMID: 23600741, 26029709). This variant is present in population databases (no rsID available, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with TFR2-related conditions. ClinVar contains an entry for this variant (Variation ID: 850883). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005047258 | SCV005674100 | likely pathogenic | Hemochromatosis type 3 | 2024-05-24 | criteria provided, single submitter | clinical testing |